ID PCSK6_HUMAN Reviewed; 969 AA. AC P29122; Q15099; Q15100; Q9UEG7; Q9UEJ1; Q9UEJ2; Q9UEJ7; Q9UEJ8; Q9UEJ9; AC Q9Y4G9; Q9Y4H0; Q9Y4H1; DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-1992, sequence version 1. DT 27-MAR-2024, entry version 219. DE RecName: Full=Proprotein convertase subtilisin/kexin type 6; DE EC=3.4.21.-; DE AltName: Full=Paired basic amino acid cleaving enzyme 4; DE AltName: Full=Subtilisin-like proprotein convertase 4; DE Short=SPC4; DE AltName: Full=Subtilisin/kexin-like protease PACE4; DE Flags: Precursor; GN Name=PCSK6; Synonyms=PACE4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PACE4A-I AND PACE4B). RC TISSUE=Hepatoma, and Kidney; RX PubMed=1741956; DOI=10.1089/dna.1991.10.757; RA Kiefer M.C., Tucker J.E., Joh R., Landsberg K.E., Saltman D., Barr P.J.; RT "Identification of a second human subtilisin-like protease gene in the RT fes/fps region of chromosome 15."; RL DNA Cell Biol. 10:757-769(1991). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PACE4C AND PACE4D). RC TISSUE=Placenta; RX PubMed=8179631; DOI=10.1006/bbrc.1994.1541; RA Tsuji A., Higashine K., Hine C., Mori K., Tamai Y., Nagamune H., RA Matsuda Y.; RT "Identification of novel cDNAs encoding human kexin-like protease, PACE4 RT isoforms."; RL Biochem. Biophys. Res. Commun. 200:943-950(1994). RN [3] RP ERRATUM OF PUBMED:8179631. RX PubMed=7980617; DOI=10.1006/bbrc.1994.2616; RA Tsuji A., Higashine K., Hine C., Mori K., Tamai Y., Nagamune H., RA Matsuda Y.; RL Biochem. Biophys. Res. Commun. 204:1381-1382(1994). RN [4] RP NUCLEOTIDE SEQUENCE (ISOFORM PACE4A-II). RC TISSUE=Placenta; RA Mori K., Imamaki A., Kii S., Nagamune H., Nagahama M., Tsuji A., RA Matsuda Y.; RT "Identification of a novel PACE4 isoform, PACE4E."; RL Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PACE4E-I AND PACE4E-II). RC TISSUE=Cerebellum; RX PubMed=9192737; DOI=10.1093/oxfordjournals.jbchem.a021677; RA Mori K., Kii S., Tsuji A., Nagahama M., Imamaki A., Hayashi K., RA Akamatsu T., Nagamune H., Matsuda Y.; RT "A novel human PACE4 isoform, PACE4E is an active processing protease RT containing a hydrophobic cluster at the carboxy terminus."; RL J. Biochem. 121:941-948(1997). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS PACE4A-I; PACE4A-II; PACE4CS; RP PACE4D; PACE4E-I AND PACE4E-II). RX PubMed=9378725; DOI=10.1093/oxfordjournals.jbchem.a021772; RA Tsuji A., Hine C., Tamai Y., Yonemoto K., Mori K., Yoshida S., Bando M., RA Sakai E., Mori K., Akamatsu T., Matsuda Y.; RT "Genomic organization and alternative splicing of human PACE4 (SPC4), RT kexin-like processing endoprotease."; RL J. Biochem. 122:438-452(1997). RN [7] RP ALTERNATIVE SPLICING (ISOFORM PACE4CS). RX PubMed=8906861; DOI=10.1016/0014-5793(96)01059-9; RA Zhong M., Benjannet S., Lazure C., Munzer S., Seidah N.G.; RT "Functional analysis of human PACE4-A and PACE4-C isoforms: identification RT of a new PACE4-CS isoform."; RL FEBS Lett. 396:31-36(1996). RN [8] RP CHARACTERIZATION. RX PubMed=10215603; DOI=10.1042/bj3390639; RA Sucic J.F., Moehring J.M., Inocencio N.M., Luchini J.W., Moehring T.J.; RT "Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can RT partly rescue the phenotype of a furin-deficient cell strain."; RL Biochem. J. 339:639-647(1999). RN [9] RP PROTEOLYTIC PROCESSING. RX PubMed=9738469; DOI=10.1016/s0014-5793(98)00970-3; RA Nagahama M., Taniguchi T., Hashimoto E., Imamaki A., Mori K., Tsuji A., RA Matsuda Y.; RT "Biosynthetic processing and quaternary interactions of proprotein RT convertase SPC4 (PACE4)."; RL FEBS Lett. 434:155-159(1998). RN [10] RP INTERACTION WITH RCN3. RX PubMed=16433634; DOI=10.1042/bj20051524; RA Tsuji A., Kikuchi Y., Sato Y., Koide S., Yuasa K., Nagahama M., Matsuda Y.; RT "A proteomic approach reveals transient association of reticulocalbin-3, a RT novel member of the CREC family, with the precursor of subtilisin-like RT proprotein convertase, PACE4."; RL Biochem. J. 396:51-59(2006). CC -!- FUNCTION: Serine endoprotease that processes various proproteins by CC cleavage at paired basic amino acids, recognizing the RXXX[KR]R CC consensus motif. Likely functions in the constitutive secretory CC pathway, with unique restricted distribution in both neuroendocrine and CC non-neuroendocrine tissues. CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000305}; CC -!- SUBUNIT: The PACE4A-I precursor protein seems to exist in the reticulum CC endoplasmic as both a monomer and a dimer-sized complex whereas mature CC PACE4A-I exists only as a monomer, suggesting that propeptide cleavage CC affects its tertiary or quaternary structure. Interacts (immature form CC including the propeptide) with RCN3; probably involved in the CC maturation and the secretion of PCSK6 (PubMed:16433634). CC {ECO:0000269|PubMed:16433634}. CC -!- INTERACTION: CC P29122; Q92824-2: PCSK5; NbExp=3; IntAct=EBI-2683528, EBI-11956269; CC P29122; Q8N8Z8: ZNF441; NbExp=3; IntAct=EBI-2683528, EBI-17216366; CC -!- SUBCELLULAR LOCATION: [Isoform PACE4A-I]: Secreted. CC -!- SUBCELLULAR LOCATION: [Isoform PACE4A-II]: Secreted. CC -!- SUBCELLULAR LOCATION: [Isoform PACE4C]: Endoplasmic reticulum. Note=Not CC secreted, remains probably in zymogen form in endoplasmic reticulum. CC -!- SUBCELLULAR LOCATION: [Isoform PACE4CS]: Endoplasmic reticulum. CC Note=Not secreted, remains probably in zymogen form in endoplasmic CC reticulum. CC -!- SUBCELLULAR LOCATION: [Isoform PACE4E-I]: Endomembrane system; CC Peripheral membrane protein. Note=Retained intracellularly probably CC through a hydrophobic cluster in their C-terminus. CC -!- SUBCELLULAR LOCATION: [Isoform PACE4E-II]: Endomembrane system; CC Peripheral membrane protein. Note=Retained intracellularly probably CC through a hydrophobic cluster in their C-terminus. CC -!- SUBCELLULAR LOCATION: [Isoform PACE4B]: Secreted. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=8; CC Name=PACE4A-I; Synonyms=PACE4; CC IsoId=P29122-1; Sequence=Displayed; CC Name=PACE4A-II; CC IsoId=P29122-2; Sequence=VSP_005436; CC Name=PACE4B; Synonyms=PACE4.1; CC IsoId=P29122-3; Sequence=VSP_005428, VSP_005429; CC Name=PACE4C; CC IsoId=P29122-4; Sequence=VSP_005432, VSP_005433; CC Name=PACE4CS; CC IsoId=P29122-5; Sequence=VSP_005430, VSP_005431; CC Name=PACE4D; CC IsoId=P29122-6; Sequence=VSP_005427, VSP_005434, VSP_005435; CC Name=PACE4E-I; CC IsoId=P29122-7; Sequence=VSP_005437; CC Name=PACE4E-II; CC IsoId=P29122-8; Sequence=VSP_005436, VSP_005437; CC -!- TISSUE SPECIFICITY: Each PACE4 isoform exhibits a unique restricted CC distribution. Isoform PACE4A-I is expressed in heart, brain, placenta, CC lung, skeletal muscle, kidney, pancreas, but at comparatively higher CC levels in the liver. Isoform PACE4A-II is at least expressed in CC placenta. Isoform PACE4B was only found in the embryonic kidney cell CC line from which it was isolated. Isoform PACE4C and isoform PACE4D are CC expressed in placenta. Isoform PACE4E-I is expressed in cerebellum, CC placenta and pituitary. Isoform PACE4E-II is at least present in CC cerebellum. CC -!- DOMAIN: The propeptide domain acts as an intramolecular chaperone CC assisting the folding of the zymogen within the endoplasmic reticulum. CC Isoform PACE4D lacks the propeptide domain. CC -!- MISCELLANEOUS: [Isoform PACE4B]: Probably enzymatically inactive. CC {ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform PACE4C]: Probably enzymatically inactive. CC {ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform PACE4CS]: Probably enzymatically inactive. CC {ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform PACE4D]: Probably enzymatically inactive. CC {ECO:0000305}. CC -!- SIMILARITY: Belongs to the peptidase S8 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M80482; AAA59998.1; -; mRNA. DR EMBL; AB001914; BAA21620.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21621.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21622.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21623.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21624.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21625.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21626.1; -; Genomic_DNA. DR EMBL; AB001914; BAA21627.1; -; Genomic_DNA. DR EMBL; D28513; BAA05871.1; -; mRNA. DR EMBL; D28514; BAA05872.1; -; mRNA. DR EMBL; D87995; BAA21793.1; -; mRNA. DR EMBL; D87993; BAA21791.1; -; mRNA. DR EMBL; D87994; BAA21792.1; -; mRNA. DR CCDS; CCDS73789.1; -. [P29122-2] DR CCDS; CCDS73790.1; -. [P29122-1] DR CCDS; CCDS73791.1; -. [P29122-5] DR CCDS; CCDS73793.1; -. [P29122-4] DR PIR; A39490; A39490. DR PIR; B39490; B39490. DR PIR; JC2191; JC2191. DR PIR; JC2192; JC2192. DR PIR; JC5570; JC5570. DR PIR; JC5571; JC5571. DR RefSeq; NP_001278238.1; NM_001291309.1. DR RefSeq; NP_002561.1; NM_002570.4. [P29122-1] DR RefSeq; NP_612192.1; NM_138319.3. [P29122-2] DR RefSeq; NP_612195.1; NM_138322.3. [P29122-3] DR RefSeq; NP_612196.1; NM_138323.2. [P29122-5] DR RefSeq; NP_612197.1; NM_138324.2. [P29122-4] DR RefSeq; NP_612198.2; NM_138325.3. DR AlphaFoldDB; P29122; -. DR SMR; P29122; -. DR BioGRID; 111083; 118. DR DIP; DIP-29903N; -. DR IntAct; P29122; 12. DR MINT; P29122; -. DR STRING; 9606.ENSP00000482760; -. DR BindingDB; P29122; -. DR ChEMBL; CHEMBL2951; -. DR GuidetoPHARMACOLOGY; 2386; -. DR MEROPS; S08.075; -. DR GlyCosmos; P29122; 4 sites, 1 glycan. DR GlyGen; P29122; 4 sites, 1 O-linked glycan (1 site). DR iPTMnet; P29122; -. DR PhosphoSitePlus; P29122; -. DR BioMuta; PCSK6; -. DR DMDM; 129542; -. DR EPD; P29122; -. DR MassIVE; P29122; -. DR MaxQB; P29122; -. DR PaxDb; 9606-ENSP00000482760; -. DR PeptideAtlas; P29122; -. DR ProteomicsDB; 54520; -. [P29122-1] DR ProteomicsDB; 54521; -. [P29122-2] DR ProteomicsDB; 54522; -. [P29122-3] DR ProteomicsDB; 54523; -. [P29122-4] DR ProteomicsDB; 54524; -. [P29122-5] DR ProteomicsDB; 54525; -. [P29122-6] DR ProteomicsDB; 54526; -. [P29122-7] DR ProteomicsDB; 54527; -. [P29122-8] DR Pumba; P29122; -. DR TopDownProteomics; P29122-3; -. [P29122-3] DR Antibodypedia; 1024; 331 antibodies from 33 providers. DR DNASU; 5046; -. DR Ensembl; ENST00000611716.5; ENSP00000482760.1; ENSG00000140479.18. [P29122-1] DR Ensembl; ENST00000611967.4; ENSP00000477768.1; ENSG00000140479.18. [P29122-4] DR Ensembl; ENST00000615296.4; ENSP00000478081.1; ENSG00000140479.18. [P29122-5] DR Ensembl; ENST00000618548.4; ENSP00000479496.1; ENSG00000140479.18. [P29122-2] DR GeneID; 5046; -. DR KEGG; hsa:5046; -. DR MANE-Select; ENST00000611716.5; ENSP00000482760.1; NM_002570.5; NP_002561.1. DR UCSC; uc032csi.2; human. [P29122-1] DR AGR; HGNC:8569; -. DR CTD; 5046; -. DR DisGeNET; 5046; -. DR GeneCards; PCSK6; -. DR HGNC; HGNC:8569; PCSK6. DR HPA; ENSG00000140479; Tissue enhanced (brain, liver, lymphoid tissue). DR MIM; 167405; gene. DR neXtProt; NX_P29122; -. DR OpenTargets; ENSG00000140479; -. DR PharmGKB; PA32895; -. DR VEuPathDB; HostDB:ENSG00000140479; -. DR eggNOG; KOG3525; Eukaryota. DR GeneTree; ENSGT00940000159506; -. DR HOGENOM; CLU_002976_4_1_1; -. DR InParanoid; P29122; -. DR OMA; CSTCTGQ; -. DR OrthoDB; 5474719at2759; -. DR PhylomeDB; P29122; -. DR TreeFam; TF314277; -. DR BRENDA; 3.4.21.61; 2681. DR BRENDA; 3.4.21.B25; 2681. DR PathwayCommons; P29122; -. DR Reactome; R-HSA-1181150; Signaling by NODAL. DR Reactome; R-HSA-167060; NGF processing. DR Reactome; R-HSA-6809371; Formation of the cornified envelope. DR Reactome; R-HSA-8963889; Assembly of active LPL and LIPC lipase complexes. DR SignaLink; P29122; -. DR SIGNOR; P29122; -. DR BioGRID-ORCS; 5046; 10 hits in 329 CRISPR screens. DR ChiTaRS; PCSK6; human. DR GeneWiki; PCSK6; -. DR GenomeRNAi; 5046; -. DR Pharos; P29122; Tchem. DR PRO; PR:P29122; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; P29122; Protein. DR Bgee; ENSG00000140479; Expressed in C1 segment of cervical spinal cord and 180 other cell types or tissues. DR ExpressionAtlas; P29122; baseline and differential. DR GO; GO:0009986; C:cell surface; IDA:BHF-UCL. DR GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:BHF-UCL. DR GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; IDA:BHF-UCL. DR GO; GO:0005796; C:Golgi lumen; TAS:Reactome. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0004175; F:endopeptidase activity; IDA:BHF-UCL. DR GO; GO:0008201; F:heparin binding; IDA:BHF-UCL. DR GO; GO:0048406; F:nerve growth factor binding; IDA:BHF-UCL. DR GO; GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL. DR GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl. DR GO; GO:0009100; P:glycoprotein metabolic process; IDA:BHF-UCL. DR GO; GO:0032902; P:nerve growth factor production; IDA:BHF-UCL. DR GO; GO:0016486; P:peptide hormone processing; IDA:BHF-UCL. DR GO; GO:0034369; P:plasma lipoprotein particle remodeling; TAS:Reactome. DR GO; GO:0016485; P:protein processing; IDA:BHF-UCL. DR GO; GO:0030510; P:regulation of BMP signaling pathway; TAS:BHF-UCL. DR GO; GO:0032940; P:secretion by cell; IDA:BHF-UCL. DR GO; GO:0007354; P:zygotic determination of anterior/posterior axis, embryo; IEA:Ensembl. DR CDD; cd00064; FU; 4. DR CDD; cd04059; Peptidases_S8_Protein_convertases_Kexins_Furin-like; 1. DR Gene3D; 2.60.120.260; Galactose-binding domain-like; 1. DR Gene3D; 3.30.70.850; Peptidase S8, pro-domain; 1. DR Gene3D; 3.40.50.200; Peptidase S8/S53 domain; 1. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR006212; Furin_repeat. DR InterPro; IPR008979; Galactose-bd-like_sf. DR InterPro; IPR032778; GF_recep_IV. DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf. DR InterPro; IPR034182; Kexin/furin. DR InterPro; IPR002884; P_dom. DR InterPro; IPR000209; Peptidase_S8/S53_dom. DR InterPro; IPR036852; Peptidase_S8/S53_dom_sf. DR InterPro; IPR023827; Peptidase_S8_Asp-AS. DR InterPro; IPR022398; Peptidase_S8_His-AS. DR InterPro; IPR023828; Peptidase_S8_Ser-AS. DR InterPro; IPR015500; Peptidase_S8_subtilisin-rel. DR InterPro; IPR010909; PLAC. DR InterPro; IPR032815; S8_pro-domain. DR InterPro; IPR038466; S8_pro-domain_sf. DR PANTHER; PTHR42884; PROPROTEIN CONVERTASE SUBTILISIN/KEXIN-RELATED; 1. DR PANTHER; PTHR42884:SF8; PROPROTEIN CONVERTASE SUBTILISIN_KEXIN TYPE 6; 1. DR Pfam; PF14843; GF_recep_IV; 1. DR Pfam; PF01483; P_proprotein; 1. DR Pfam; PF00082; Peptidase_S8; 1. DR Pfam; PF16470; S8_pro-domain; 1. DR PRINTS; PR00723; SUBTILISIN. DR SMART; SM00181; EGF; 5. DR SMART; SM00261; FU; 5. DR SUPFAM; SSF49785; Galactose-binding domain-like; 1. DR SUPFAM; SSF57184; Growth factor receptor domain; 2. DR SUPFAM; SSF54897; Protease propeptides/inhibitors; 1. DR SUPFAM; SSF52743; Subtilisin-like; 1. DR PROSITE; PS51829; P_HOMO_B; 1. DR PROSITE; PS50900; PLAC; 1. DR PROSITE; PS51892; SUBTILASE; 1. DR PROSITE; PS00136; SUBTILASE_ASP; 1. DR PROSITE; PS00137; SUBTILASE_HIS; 1. DR PROSITE; PS00138; SUBTILASE_SER; 1. DR Genevisible; P29122; HS. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Cleavage on pair of basic residues; KW Endoplasmic reticulum; Glycoprotein; Hydrolase; Membrane; Protease; KW Reference proteome; Repeat; Secreted; Serine protease; Signal; Zymogen. FT SIGNAL 1..63 FT /evidence="ECO:0000255" FT PROPEP 64..149 FT /evidence="ECO:0000269|PubMed:9738469" FT /id="PRO_0000027110" FT CHAIN 150..969 FT /note="Proprotein convertase subtilisin/kexin type 6" FT /id="PRO_0000027111" FT DOMAIN 168..487 FT /note="Peptidase S8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01240" FT DOMAIN 495..635 FT /note="P/Homo B" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01173" FT REPEAT 692..739 FT /note="FU 1" FT REPEAT 743..790 FT /note="FU 2" FT REPEAT 794..838 FT /note="FU 3" FT REPEAT 842..887 FT /note="FU 4" FT REPEAT 895..943 FT /note="FU 5" FT DOMAIN 931..969 FT /note="PLAC" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00233" FT REGION 1..39 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 658..683 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 695..930 FT /note="CRM (Cys-rich motif)" FT MOTIF 553..555 FT /note="Cell attachment site" FT /evidence="ECO:0000255" FT COMPBIAS 1..16 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 205 FT /note="Charge relay system" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01240" FT ACT_SITE 246 FT /note="Charge relay system" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01240" FT ACT_SITE 420 FT /note="Charge relay system" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01240" FT SITE 149..150 FT /note="Cleavage; by autolysis" FT /evidence="ECO:0000269|PubMed:9738469" FT CARBOHYD 259 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 914 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 932 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 1..167 FT /note="Missing (in isoform PACE4D)" FT /evidence="ECO:0000303|PubMed:8179631" FT /id="VSP_005427" FT VAR_SEQ 471 FT /note="K -> KGAAVAFWWTIGWPWNV (in isoform PACE4B)" FT /evidence="ECO:0000303|PubMed:1741956" FT /id="VSP_005428" FT VAR_SEQ 472..969 FT /note="Missing (in isoform PACE4B)" FT /evidence="ECO:0000303|PubMed:1741956" FT /id="VSP_005429" FT VAR_SEQ 621..664 FT /note="KLKEWSLILYGTAEHPYHTFSAHQSRSRMLELSAPELEPPKAAL -> DLET FT PVANQLTTEERFVSTPSILFHWSVYLSWSQYHIVLITVAL (in isoform FT PACE4D)" FT /evidence="ECO:0000303|PubMed:8179631" FT /id="VSP_005434" FT VAR_SEQ 621..652 FT /note="KLKEWSLILYGTAEHPYHTFSAHQSRSRMLEL -> DLETPVANQLTTEERE FT PGLKHVFRWQIEQELW (in isoform PACE4C)" FT /evidence="ECO:0000303|PubMed:8179631" FT /id="VSP_005432" FT VAR_SEQ 621..623 FT /note="KLK -> NLD (in isoform PACE4CS)" FT /evidence="ECO:0000305" FT /id="VSP_005430" FT VAR_SEQ 624..969 FT /note="Missing (in isoform PACE4CS)" FT /evidence="ECO:0000305" FT /id="VSP_005431" FT VAR_SEQ 653..969 FT /note="Missing (in isoform PACE4C)" FT /evidence="ECO:0000303|PubMed:8179631" FT /id="VSP_005433" FT VAR_SEQ 665..969 FT /note="Missing (in isoform PACE4D)" FT /evidence="ECO:0000303|PubMed:8179631" FT /id="VSP_005435" FT VAR_SEQ 680..693 FT /note="AQSTPGSANILQTS -> G (in isoform PACE4A-II and FT isoform PACE4E-II)" FT /evidence="ECO:0000303|PubMed:9192737" FT /id="VSP_005436" FT VAR_SEQ 901..969 FT /note="CDENCLSCAGSSRNCSRCKTGFTQLGTSCITNHTCSNADETFCEMVKSNRLC FT ERKLFIQFCCRTCLLAG -> YGPPGGERQATVSSKGVPGGQSLSASSPGAGEGMLHHP FT TVDRSPFTELLRGLRPFVHWMHICWVPAVGRHRAAAG (in isoform PACE4E-I FT and isoform PACE4E-II)" FT /evidence="ECO:0000303|PubMed:9192737" FT /id="VSP_005437" FT VARIANT 502 FT /note="C -> R (in dbSNP:rs1058260)" FT /id="VAR_051824" FT CONFLICT 639 FT /note="T -> I (in Ref. 6; FT BAA21624/BAA21625/BAA21626/BAA21627)" FT /evidence="ECO:0000305" SQ SEQUENCE 969 AA; 106420 MW; A3599CC278D09B05 CRC64; MPPRAPPAPG PRPPPRAAAA TDTAAGAGGA GGAGGAGGPG FRPLAPRPWR WLLLLALPAA CSAPPPRPVY TNHWAVQVLG GPAEADRVAA AHGYLNLGQI GNLEDYYHFY HSKTFKRSTL SSRGPHTFLR MDPQVKWLQQ QEVKRRVKRQ VRSDPQALYF NDPIWSNMWY LHCGDKNSRC RSEMNVQAAW KRGYTGKNVV VTILDDGIER NHPDLAPNYD SYASYDVNGN DYDPSPRYDA SNENKHGTRC AGEVAASANN SYCIVGIAYN AKIGGIRMLD GDVTDVVEAK SLGIRPNYID IYSASWGPDD DGKTVDGPGR LAKQAFEYGI KKGRQGLGSI FVWASGNGGR EGDYCSCDGY TNSIYTISVS SATENGYKPW YLEECASTLA TTYSSGAFYE RKIVTTDLRQ RCTDGHTGTS VSAPMVAGII ALALEANSQL TWRDVQHLLV KTSRPAHLKA SDWKVNGAGH KVSHFYGFGL VDAEALVVEA KKWTAVPSQH MCVAASDKRP RSIPLVQVLR TTALTSACAE HSDQRVVYLE HVVVRTSISH PRRGDLQIYL VSPSGTKSQL LAKRLLDLSN EGFTNWEFMT VHCWGEKAEG QWTLEIQDLP SQVRNPEKQG KLKEWSLILY GTAEHPYHTF SAHQSRSRML ELSAPELEPP KAALSPSQVE VPEDEEDYTA QSTPGSANIL QTSVCHPECG DKGCDGPNAD QCLNCVHFSL GSVKTSRKCV SVCPLGYFGD TAARRCRRCH KGCETCSSRA ATQCLSCRRG FYHHQEMNTC VTLCPAGFYA DESQKNCLKC HPSCKKCVDE PEKCTVCKEG FSLARGSCIP DCEPGTYFDS ELIRCGECHH TCGTCVGPGR EECIHCAKNF HFHDWKCVPA CGEGFYPEEM PGLPHKVCRR CDENCLSCAG SSRNCSRCKT GFTQLGTSCI TNHTCSNADE TFCEMVKSNR LCERKLFIQF CCRTCLLAG //